OpGen

OpGen EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of OpGen (OPGN) as of Oct 19, 2026 is -309.68. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -75.00 — a change of 312.91% (lower).

EV/FCF

-309.68

YoY

312.91%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of OpGen is 2025 -309.68 . EV/FCF (Enterprise Value to Free Cash Flow) of OpGen was 2024 -75.00 . It decreases by 312.91% lower compared to the previous year.

The OpGen EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-32.31 USD
Jan 1, 2019
-31.83 USD
Jan 1, 2020
-15.93 USD
Jan 1, 2021
-15.10 USD
Jan 1, 2022
-17.71 USD
Jan 1, 2023
-24.94 USD
Jan 1, 2024
-75.00 USD
Jan 1, 2025
-309.68 USD
The OpGen EV/FCF history
YEAREV/FCFYoY
-309.68+312.91%
-75.00+200.70%
-24.94+40.83%
-17.71+17.27%
-15.10-5.18%
-15.93-49.97%
-31.83-1.47%
-32.31+29.18%
-25.01+19.88%
-20.86-15.96%
-24.82-63.38%
-67.78—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

EV/FCF (Enterprise Value to Free Cash Flow) of OpGen is -309.68 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of OpGen changed from -75.00 to -309.68, representing a 312.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) OpGen since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s OpGen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — OpGen

All Key Metrics — OpGen